This paper evaluates the performance of five distinct neural network models in predicting the antitubercular activity of oxazolines and oxazoles derivatives. The models include single hidden layer feed forward neural network (SHLFNN), gradient descent back propagation neural network (GDBPNN), gradient descent back propagation with momentum neural network (GDBPMNN), back propagation with weight decay neural network (BPWDNN), and quantile regression neural network (QRNN), with QRNN demonstrating superior predictive accuracy. The study illustrates how neural networks can effectively model non-linear molecular descriptor data for drug discovery.